Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 204.45%13.88B | 106.92%13.04B | 61.98%4.56B | 36.46%6.3B | 19.29%2.81B | 2.82%4.62B | 33.07%2.36B | 78.66%4.49B | 116.75%1.77B | 49.31%2.51B |
| Operating income | 204.45%13.88B | 106.92%13.04B | 61.98%4.56B | 36.46%6.3B | 19.29%2.81B | 2.82%4.62B | 33.07%2.36B | 78.66%4.49B | 116.75%1.77B | 49.31%2.51B |
| Cost of sales | -151.12%-4.12B | -77.68%-4.33B | -46.91%-1.64B | -24.16%-2.44B | -12.85%-1.12B | -13.32%-1.96B | -50.78%-988.41M | -88.39%-1.73B | -130.53%-655.51M | -55.01%-919.36M |
| Operating expenses | -151.12%-4.12B | -77.68%-4.33B | -46.91%-1.64B | -24.16%-2.44B | -12.85%-1.12B | -13.32%-1.96B | -50.78%-988.41M | -88.39%-1.73B | -130.53%-655.51M | -55.01%-919.36M |
| Gross profit | 234.39%9.76B | 125.35%8.71B | 71.88%2.92B | 45.56%3.86B | 23.93%1.7B | -3.77%2.65B | 22.68%1.37B | 73.05%2.76B | 109.41%1.12B | 46.20%1.59B |
| Selling expenses | -135.93%-3.19B | -82.09%-3.65B | -54.07%-1.35B | -36.30%-2B | -26.70%-878.32M | -32.97%-1.47B | -65.14%-693.23M | -75.55%-1.11B | -88.22%-419.78M | -73.18%-630.07M |
| Administrative expenses | -77.35%-770.41M | -33.90%-947.09M | -31.14%-434.41M | -3.06%-707.3M | -2.66%-331.25M | -23.10%-686.28M | -34.63%-322.68M | -99.13%-557.51M | -91.13%-239.67M | -96.51%-279.97M |
| Impairment and provision | 71.19%-746K | -362.55%-3.45M | -2,625.26%-2.59M | 83.44%-745K | -218.75%-95K | -213.59%-4.5M | 102.43%80K | -460.55%-1.44M | -437.36%-3.3M | 112.90%398K |
| -Other impairment is provision | 71.19%-746K | -362.55%-3.45M | -2,625.26%-2.59M | 83.44%-745K | -218.75%-95K | -213.59%-4.5M | 102.43%80K | -460.55%-1.44M | -437.36%-3.3M | 112.90%398K |
| Special items of operating profit | 10,024.20%246.42M | -40.11%47.51M | -105.06%-2.48M | -12.22%79.33M | -46.36%49.07M | 60.77%90.37M | 182.60%91.48M | 63.82%56.21M | 44.65%32.37M | 92.41%34.31M |
| Operating profit | 436.55%6.04B | 237.57%4.15B | 109.46%1.13B | 110.95%1.23B | 20.56%537.76M | -49.26%583.38M | -8.35%446.06M | 59.97%1.15B | 133.57%486.69M | 20.04%718.78M |
| Financing income | -11.44%93.87M | 15.26%212.34M | 33.14%105.99M | 172.18%184.22M | 246.26%79.61M | 136.58%67.68M | 65.55%22.99M | 1,364.87%28.61M | 1,886.84%13.89M | 360.61%1.95M |
| Financing cost | -27.66%-28.36M | -51.48%-48.98M | -37.37%-22.22M | 16.18%-32.34M | -1.21%-16.17M | -81.58%-38.58M | -95.85%-15.98M | -94.10%-21.25M | -76.47%-8.16M | -88.30%-10.95M |
| Special items of earning before tax | 161.02%47.63M | 45.02%48.19M | 5.19%18.25M | 22.86%33.23M | 256.33%17.35M | 92.97%27.05M | 17.58%4.87M | 687.18%14.02M | 154.75%4.14M | -148.03%-2.39M |
| Earning before tax | 401.20%6.16B | 208.37%4.37B | 98.60%1.23B | 121.37%1.42B | 35.07%618.55M | -45.39%639.53M | -7.78%457.94M | 65.56%1.17B | 152.21%496.56M | 18.22%707.4M |
| Tax | -458.15%-1.48B | -223.40%-1.06B | -87.04%-264.3M | -99.71%-326.98M | -13.05%-141.31M | 48.29%-163.73M | 9.27%-124.99M | -71.99%-316.62M | -147.77%-137.76M | -25.01%-184.09M |
| After-tax profit from continuing operations | 385.58%4.68B | 203.86%3.31B | 102.02%964.14M | 128.83%1.09B | 43.34%477.24M | -44.32%475.8M | -7.21%332.95M | 63.30%854.57M | 153.96%358.8M | 16.00%523.31M |
| Earning after tax | 385.58%4.68B | 203.86%3.31B | 102.02%964.14M | 128.83%1.09B | 43.34%477.24M | -44.32%475.8M | -7.21%332.95M | 63.30%854.57M | 153.96%358.8M | 16.00%523.31M |
| Minority profit | 150.75%107.35M | 2,745.37%182.87M | 6,318.14%42.81M | 4,458.16%6.43M | 433.60%667K | -38.16%141K | 123.21%125K | 218.13%228K | 175.68%56K | ---193K |
| Profit attributable to shareholders | 396.49%4.57B | 188.77%3.13B | 93.32%921.33M | 127.55%1.08B | 43.19%476.58M | -44.32%475.66M | -7.23%332.82M | 63.20%854.34M | 153.78%358.74M | 16.05%523.51M |
| Basic earnings per share | 395.28%3.4417 | 191.36%2.36 | 95.97%0.6949 | 131.43%0.81 | 46.65%0.3546 | -43.55%0.35 | -7.14%0.2418 | 40.91%0.62 | 112.05%0.2604 | 12.82%0.44 |
| Diluted earnings per share | 395.45%3.4295 | 190.12%2.35 | 95.43%0.6922 | 131.43%0.81 | 46.55%0.3542 | -43.55%0.35 | -7.11%0.2417 | 40.91%0.62 | 111.89%0.2602 | 12.82%0.44 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PwC Accounting Firm | -- | PwC Accounting Firm | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.